1
Lenalidomide in the Treatment of Mucosal Behçet’s Syndrome
Condition(s):Oral UlcerLast Updated:April 7, 2023Recruiting
Lenalidomide: 1171 Clinical Trials, Page 1 of 118
Hide Studies Not Open or Pending
2
Lenalidomide in Anti-MAG Neuropathy: Phase 1b Study
Condition(s):Demyelinating Sensorimotor NeuropathyLast Updated:November 4, 2021Active, not recruiting
3
A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden in Participants With Relapsed or Refractory Mantle Cell Lymphoma
Condition(s):Lymphoma, Mantle-CellLast Updated:October 21, 2022Recruiting
4
Evaluation of the Immune Restoration Potential Of Lenalidomide
Condition(s):Chronic Lymphocytic Leukemia (CLL)Last Updated:April 28, 2017Withdrawn
5
Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease
Condition(s):Leukemia, Myeloid; Myelodysplastic SyndromesLast Updated:January 27, 2020Terminated
6
Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC
Condition(s):Advanced HCCLast Updated:April 26, 2023Not yet recruiting
7
Lenalidomide in the Treatment of Refractory Cutaneous Dermatomyositis
Condition(s):DermatomyositisLast Updated:August 4, 2022Not yet recruiting
8
Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia
Condition(s):Waldenstrom MacroglobulinemiaLast Updated:June 7, 2017Completed
9
Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q)
Condition(s):Myelodysplastic SyndromeLast Updated:August 19, 2022Completed
10
A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia
Condition(s):Leukemia, MyeloidLast Updated:January 7, 2020Completed